No Data
Here's What Analysts Are Forecasting For Heron Therapeutics, Inc. (NASDAQ:HRTX) After Its First-Quarter Results
Heron Therapeutics, Inc. (NASDAQ:HRTX) just released its latest first-quarter results and things are looking bullish. Results overall were solid, with revenues arriving 5.1% better than analyst f
Heron Therapeutics, Inc. (NASDAQ:HRTX) Q1 2024 Earnings Call Transcript
Express News | Needham Reiterates Buy on Heron Therapeutics, Maintains $5 Price Target
Heron Therapeutics Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/08/2024 70.65% Needham → $5 Reiterates Buy → Buy 04/23/2024 104.78% Capital One → $6 Initiates Coverage
Heron Therapeutics Inc (HRTX) Q1 2024 Earnings Call Transcript Highlights: Significant ...
Q1 2024 Heron Therapeutics Inc Earnings Call